It doesn’t take a research study to tell us that the typical American diet is crap. We eat foods full of saturated fats, which are difficult to break down, and way too much of most foods.   Over 25% of the American population is estimated to be obese, according to the Center for Disease Control(CDC).   Obesity can lead to severe health problems including diabetes, heart disease and stroke.

But somehow our diet stays the same. However, changing our eating habits to resemble a more Mediterranean Diet can help prevent some of these health problems, according to a wave of studies over the last year.

Rene Descartes, father of modern philosophy and analytical geometry, is perhaps best known for his simple statement: Cogito, ergo sum. I think, therefore I am (or I am thinking, therefore I exist).

GENEVA, Switzerland, February 19 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that the European Medicines Agency (EMEA) has recommended to the European Commission the suspension of the marketing authorization for Raptiva(R) (efalizumab). Raptiva(R) is currently approved for the treatment of adult patients with moderate to severe chronic plaque psoriasis who have failed to respond to, or who have a contraindication to, or are intolerant to certain other systemic therapies.

LONDON, February 19 /PRNewswire/ --

BARCELONA, Spain, February 19 /PRNewswire/ --

The GSMA today reported that more than 47,000* visitors from 189 countries attended the GSMA Mobile World Congress, the leading event for the mobile communications industry. The four-day conference and exhibition attracted executives from the world's largest and most influential mobile operators, software companies, equipment providers, Internet companies and media and entertainment organisations, as well as government delegations. 50 per cent of Mobile World Congress attendees hold C-level positions, including more than 2,800 CEOs.

FRANKFURT, Germany, February 19 /PRNewswire/ --

- Solution Provider Hits Another Milestone

RTS Realtime Systems Group, a leading trading solutions provider, announced today that it is the first trading solutions provider that has passed the conformance test for the NYSE Euronext Universal Trading Platform's Common Customer Gateway via UTP-Direct protocol. The newly designed Universal Trading Platform replaced the market platform NSC for NYSE Euronext's European cash regulated market.

LONDON, February 19 /PRNewswire/ -- Unite, the UK's largest union, has expressed astonishment at today's (Thursday, 19th) announcement by HP that it proposes to cut the pay of its entire global workforce by up to 5%, with more for senior executives.

The announcement was made as part of the HP reporting of its first quarter results for 2009, with revenue growth of 1% compared to last year to GBP20bn, with profits of GBP1.3bn.

Peter Skyte, Unite national officer, said:

UK employees who have made a key contribution to the doubling of the HP services revenue and borne the brunt of redundancies in Europe will be astonished that a company that is increasing revenue and still making substantial profits is seeking a pay cut from its UK workforce.

LONDON, February 19 /PRNewswire/ --

- Eisai Set to Become an Emerging Leader in the Treatment of Epilepsy

Eisai Europe Ltd (London; Chairman CEO Yutaka Tsuchiya), the European subsidiary of Eisai Co., Ltd. (Tokyo, President CEO: Haruo Naito), and Bial-Portela CA, S.A., (S. Mamede do Coronado, Portugal, CEO Dr Luis Portela) today announced the signing of a licence and co-promotion agreement in which Eisai receives a sole license to market, promote and distribute the novel once daily anti-epileptic Zebinix(R) (eslicarbazepine acetate), within Europe(1).

REYKJAVIK, Iceland, February 19 /PRNewswire/ --

- Licensing round ongoing for largest accessible, undrilled oil frontier

Evidence is growing that oil may be found in the Dreki area, northeast of Iceland. Recent seismic studies and re-evaluation of available data indicate the presence of thick Mesozoic sediments, similar to those found in the adjacent and geologically-related oil areas of Norway and Greenland. Surface pockmarks, which are known to cluster around major hydrocarbon fields in the North Sea, were also recently discovered in the area.

SAINT-PREX, Switzerland, February 19 /PRNewswire/ --

- New Gonadotrophin-Releasing Hormone (GnRH) Receptor Antagonist Demonstrates Rapid, Long-Term Suppression of Testosterone

Ferring Pharmaceuticals announced today that it has received marketing authorisation from the European Commission, for FIRMAGON(R) (degarelix), a new GnRH receptor antagonist indicated for patients with advanced, hormone-dependent prostate cancer.

In Phase III studies degarelix produced a significant reduction in levels of testosterone (i,ii) within three days in more than 96% of study patients.(ii) Testosterone plays a major role in the growth and spread of prostate cancer cells.